Search - tctmd.com

Displaying 101 - 120 of 1181

Sort: Relevancy | Date

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

News Conference News NY Valves 2024

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

Michael O'Riordan

June 11, 2024

News Daily News

AHA Celebrates a Century by Looking Back, and Forward

Shelley Wood

June 10, 2024

News Conference News HRS 2024

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

L.A. McKeown

May 23, 2024

News Conference News EuroPCR 2024

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

Yael L. Maxwell

May 22, 2024

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

News Conference News EuroPCR 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Michael O'Riordan

May 16, 2024

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

Presentation EuroPCR 2024

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

Presenter: Frederik Zimmermann

May 15, 2024

Presentation EuroPCR 2024

Hybrid coronary revascularisation–10-year clinical outcomes of the prospective randomised study.

Presenter: Mateusz Tajstra

May 15, 2024

Presentation EuroPCR 2024

Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement

Presenter: Eliano Navarese

May 15, 2024

News Conference News EuroPCR 2024

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Michael O'Riordan

May 14, 2024

Presentation EuroPCR 2024

Short Methodology Insight - NOTION-2

Presenter: Davide Capodanno

May 14, 2024

News Opinion Off Script

The Future of Cardiothoracic Surgery, Too, Lies in Innovation

Friedhelm Beyersdorf, MD

May 13, 2024

News Conference News

Concomitant AF Procedures During Non-Mitral Surgery Less Likely in Women

Yael L. Maxwell

May 09, 2024

News Daily News

Certain Periprocedural MIs Don’t Matter, New Data Allege

Michael O'Riordan

May 09, 2024

News Conference News

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

Yael L. Maxwell

May 06, 2024

News Daily News

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Yael L. Maxwell

May 01, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

Advertisement

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

AHA Celebrates a Century by Looking Back, and Forward

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

Hybrid coronary revascularisation–10-year clinical outcomes of the prospective randomised study.

Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Short Methodology Insight - NOTION-2

The Future of Cardiothoracic Surgery, Too, Lies in Innovation

Concomitant AF Procedures During Non-Mitral Surgery Less Likely in Women

Certain Periprocedural MIs Don’t Matter, New Data Allege

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content